| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/27/2005 | US6949694 Genetic control of flowering in plants and cloning and expression of genes involved therein, in particular, cloning and expression of FY gene of Arabidopsis thaliana and manipulation and use of these genes in plants |
| 09/27/2005 | US6949693 Promoters for gene expression in caryopses of plants |
| 09/27/2005 | US6949692 Detection of genetic position of preferential mutation in rodents; obtain rodent, mate, monitor offspring for preferential phenotypes, mate offspring, monitor expression of mutant phenotypes |
| 09/27/2005 | US6949691 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies |
| 09/27/2005 | US6949659 cyanine, xanthene, porphyrin or coumarin dyes, used for marking probes, including nucleic acids and proteins |
| 09/27/2005 | US6949635 use with DNA polymerases that are thermostable or which contain an altered dNMP binding site |
| 09/27/2005 | US6949634 Kit for gneration of preferential complmentary nucleotide sequences |
| 09/27/2005 | US6949633 Primers useful for sizing nucleic acids |
| 09/27/2005 | US6949628 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection |
| 09/27/2005 | US6949627 a purified polyclonal or monoclonal antibody which recognizes an epitope of a surface protein of a merozoite of Plasmodium falciparum; capable of inducing a resistance to the parasite so it can be used as a vaccine |
| 09/27/2005 | US6949626 Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor |
| 09/27/2005 | US6949623 Amplification of efficiency of gene tranfer into cells; obtain cells, icubate with genetically engineered retrovirus, transduce cells, recover transformed cells |
| 09/27/2005 | US6949520 Methods related to immunostimulatory nucleic acid-induced interferon |
| 09/27/2005 | US6949512 administering to patient effective amount of lipopolysaccharide binding protein to elevate serum concentration of lipopolysaccharide binding protein in patient to sufficiently high level to suppress lipopolysaccharide induced release of cytokine |
| 09/27/2005 | US6949506 Relaxin-like factor and methods and uses thereof |
| 09/27/2005 | US6949383 Mutagenesis method |
| 09/27/2005 | US6949381 Immortalized human skin cell lines and novel serum-free medium useful for the production thereof |
| 09/27/2005 | US6949380 culturing a proliferating epidermal basal cell population, exposing the cell(s) to fetuin, noggin, chordin, gremlin, follistatin, growing the cell(s) in the presence of an antisense oligonucleotide antagonist of bone morphogenetic protein (BMP) |
| 09/27/2005 | US6949379 Aptamer-mediated regulation of gene expression |
| 09/27/2005 | US6949376 Nucleic acid amplification reaction station for disposable test devices |
| 09/27/2005 | US6949373 given amino acid sequence; telomerase motif; use as drug target for cancer |
| 09/27/2005 | US6949372 Engineering intracellular sialylation pathways |
| 09/27/2005 | US6949366 Complexing; purified polypeptide |
| 09/27/2005 | US6949364 An isolated DNA encoding a protein, has testicular differentiation activity |
| 09/27/2005 | US6949362 Rhodococcus cloning and expression vectors |
| 09/27/2005 | US6949361 Polynucleotide |
| 09/27/2005 | US6949360 DNA coding for human cell surface antigen |
| 09/27/2005 | US6949357 Reagents and methods useful for detecting diseases of the urinary tract |
| 09/27/2005 | US6949356 Methods for improving secondary metabolite production in fungi |
| 09/27/2005 | US6949353 capable of acting as an guanylyltransferase and methyltransferase consisting of a polypeptide from the N-terminus of flavivirus genus RNA-dependent RNA polymerase |
| 09/27/2005 | US6949349 incubating a phagemid clone displaying the peptide, with the IGF in the presence of the IGFBP at high and low concentrations of the phagemid clone, measuring the degree to which binding of the phagemid clone to the IGFBP is inhibited by IGF |
| 09/27/2005 | US6949338 Methods and kits for obtaining and analyzing skin samples for the detection of nucleic acids |
| 09/27/2005 | US6949337 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it |
| 09/27/2005 | US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections |
| 09/27/2005 | US6949244 produced by hybridoma cell line ATCC No. HB 12020; elicits an immune response against (human milk fat globule) HMFG in non-human primates |
| 09/27/2005 | US6949242 Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells |
| 09/27/2005 | US6949087 Apparatus with weeping tip and method of use |
| 09/27/2005 | CA2391368C Genes and methods for manipulation of growth |
| 09/27/2005 | CA2270289C Proteins with enhanced levels of essential amino acids |
| 09/27/2005 | CA2250682C Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 09/27/2005 | CA2149120C Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 09/27/2005 | CA2139670C Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein |
| 09/27/2005 | CA2099612C Monokine mig induced by ifn-gamma |
| 09/27/2005 | CA2079814C Cationic lipids for intracellular delivery of biologically active molecules |
| 09/22/2005 | WO2005088308A2 Fluorescent signal emitting live cell biosensor molecules and dyes for detection and quantification of protein activities |
| 09/22/2005 | WO2005088288A1 Carbon nanotube biosensor |
| 09/22/2005 | WO2005087950A1 Method of detecting nucleic acid using amplification on an array |
| 09/22/2005 | WO2005087947A2 Bioengineered proteolytic enzymes with enhanced specificity for cytokine receptors |
| 09/22/2005 | WO2005087942A1 Process for expresson of foreign genes in methylotrophic bacteria through chromosomal integration |
| 09/22/2005 | WO2005087941A1 Process for producing l-fuculose and process for producing l-fucose |
| 09/22/2005 | WO2005087936A1 Method of transferring gene into embryonic stem cell |
| 09/22/2005 | WO2005087935A1 Methods for screening for genes and small molecules that activate mammalian receptor proteins |
| 09/22/2005 | WO2005087934A2 Barley for production of flavor-stable beverage |
| 09/22/2005 | WO2005087933A1 Thiol methyltransferase-based selection |
| 09/22/2005 | WO2005087932A2 Vectors for directional cloning |
| 09/22/2005 | WO2005087931A1 Modified oncolytic viruses |
| 09/22/2005 | WO2005087930A1 Polynucleotides for the detection of escherichia coli o157 |
| 09/22/2005 | WO2005087929A1 Infectious aetiology of prostatic disease and methods to identify causative agents |
| 09/22/2005 | WO2005087928A1 Proteins imparting boron-tolerance and genes thereof |
| 09/22/2005 | WO2005087927A1 Method for preparation and purification or recombinant proteins |
| 09/22/2005 | WO2005087926A2 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 09/22/2005 | WO2005087925A1 Recombinant gene, disease animal model and method of evaluating test substance |
| 09/22/2005 | WO2005087924A1 Dna chip and method of extracting disease-associated genes |
| 09/22/2005 | WO2005087923A1 A small synthetic rna, a method of preparing the same and uses thereof |
| 09/22/2005 | WO2005087922A1 Altered expression in filamentous fungi |
| 09/22/2005 | WO2005087911A1 Microbe culturing apparatus and utilizing the same, hydrogen production apparatus and fuel cell system |
| 09/22/2005 | WO2005087810A2 Dimeric fusion proteins and materials and methods for producing them |
| 09/22/2005 | WO2005087807A1 Vr1 receptors and uses thereof |
| 09/22/2005 | WO2005087802A2 Process for producing polypeptides |
| 09/22/2005 | WO2005087790A1 A nucleotide specific for o-antigen of escherichia coli o114 type |
| 09/22/2005 | WO2005087784A1 Electrochemically active ligand for sequence-specific detection of double-stranded nucleic acid molecule |
| 09/22/2005 | WO2005087249A1 Protease inhibitor and preventives or remedies for diseases |
| 09/22/2005 | WO2005086993A1 Method for preparing transgenic pepper using callus induction |
| 09/22/2005 | WO2005086938A2 Artificial mutation controls for diagnostic testing |
| 09/22/2005 | WO2005086934A2 Enriched cdna expression libraries and methods of making and using same |
| 09/22/2005 | WO2005086922A2 Oncolytic adenovirus armed with therapeutic genes |
| 09/22/2005 | WO2005086907A2 Biosynthetic gene cluster for ambruticins |
| 09/22/2005 | WO2005086896A2 Delivery vectors for short interfering rna, micro-rna and antisense rna |
| 09/22/2005 | WO2005086875A2 A humanized anti-cea t84.66 antibody and uses thereof |
| 09/22/2005 | WO2005086835A2 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
| 09/22/2005 | WO2005086825A2 Methods and compositions for treatment of diseases associated with aberrant microsatellite expansion |
| 09/22/2005 | WO2005086813A2 Glutamine-rich maize seed protein and promoter |
| 09/22/2005 | WO2005086794A2 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor |
| 09/22/2005 | WO2005086775A2 Lumen-exposed molecules and methods for targeted delivery |
| 09/22/2005 | WO2005086695A2 Intracellular interleukin-1 receptor antagonist and uses thereof |
| 09/22/2005 | WO2005086670A2 Production of chemicals from lignocellulose, biomass or sugars |
| 09/22/2005 | WO2005086667A2 High efficiency peptide production in plant cells |
| 09/22/2005 | WO2005086654A2 Self-cleaving affinity tags and methods of use |
| 09/22/2005 | WO2005086595A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna |
| 09/22/2005 | WO2005080418A3 Multimerised hiv fusion inhibitors |
| 09/22/2005 | WO2005073384A3 Human soluble neuropilin-1 primary polyadenylation signal and uses thereof |
| 09/22/2005 | WO2005070214A8 Peptides for inhibiting insects |
| 09/22/2005 | WO2005069913A3 Expression of mammalian proteins in pseudomonas fluorescens |
| 09/22/2005 | WO2005068498A3 Human therapeutic cells secreting nerve growth factor |
| 09/22/2005 | WO2005058946A3 Methods for enhancing expression of recombinant proteins |
| 09/22/2005 | WO2005056020B1 Nf-kb oligonucleotide decoy molecules |
| 09/22/2005 | WO2005052143A3 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses |
| 09/22/2005 | WO2005044981A3 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 09/22/2005 | WO2005038018A8 Cloning of cytochrome p450 genes from nicotiana |
| 09/22/2005 | WO2005038006A8 Chimeric metabotropic glutamate receptors and uses thereof |